The significance of an impaired psychosocial stress response on therelease of reactive metabolites as a possible cause of diabeticcomplications

心理社会压力反应受损对反应性代谢物释放的重要性作为糖尿病并发症的可能原因

基本信息

项目摘要

Previous research showed that in diabetes mellitus reactive metabolites such as methylglyoxal are elevated and accumulate. This can lead to long-term diabetic complications such as retinopathy, nephropathy, albminuria and/or neuropathy. There are also studies indicating that psychosocial stress leads to the accumulation of reactive metabolites. The goal of this proposed project is to examine and understand the association between psychological stress and the release of reactive metabolites with long-term complications in patients with diabetes mellitus. Accordingly, an experimental design will be undertaken with n=120 participants: 40 diabetic patients with complications, 40 without complications, and 40 healthy controls. Every participant will receive a thorough psychosomatic evaluation in the form of a questionnaire and the Structured Clinical Interview for DSM-IV (SCID). Stress levels and everyday stressors of the participants will be assessed using the Perceived Stress Scale (PSS), the Trier Inventory for the Assessment of Chronic Stress (TICS), and a Daily Stress Inventory (Alltagsbelastungsfragebogen, ABF). An experimental stress-provocation will be done in the form of the Trier Social Stress Tests (TSST). Both before and after the TSST, blood and saliva samples will be taken. The blood tests will be used to determine glucose, adrenalin, noradrenalin, and ACTH; as well as methylglyoxal and glyoxal and their glycation endproducts, and the total antioxidative capacity. In addition, the saliva tests will be used to measure cortisol activity.A prevalent hypothesis of this study is that the basal level of reactive metabolites is positively correlated with indicators of chronic stress (such as cortisol, heart rate, and subjective measurements). In addition, it is assumed that after acute stress episodes the dynamic change of reactive metabolites will be disturbed in a subgroup of diabetic patients. The central hypothesis is the assumption that the stress-induced dysbalance between production and decomposition of reactive metabolites will be more accentuated in patients with diabetic complications compared to those without complications. According to our understanding, this proposed project is the first three-group comparison design with repeated measurements, devised to examine the relationship between chronic stress, acute stress, methylglyoxal- and glyoxal- level (and changes), and diabetic complications. A close cooperation with the SFB 1118 'Reaktive Metabolite als Ursache diabetischer Folgeschäden' ('Reactive Metabolites as a Cause of Consequent Diabetic Complications') will be undertaken. In the context of a wider frame of reference, this study will serve as the basis for possible identification of the various stress-reactive patient groups that could benefit from stress-reduction therapy.
先前的研究表明,在糖尿病中,反应性代谢产物,如甲基乙二醛,会升高并积聚。这可能会导致长期的糖尿病并发症,如视网膜病变、肾病、白蛋白尿和/或神经病变。也有研究表明,心理社会压力会导致反应性代谢物的积累。这项拟议项目的目标是检查和了解糖尿病患者心理应激和反应性代谢产物的释放与长期并发症之间的联系。因此,将进行一项实验设计,n=120名参与者:40名有并发症的糖尿病患者,40名无并发症的糖尿病患者,以及40名健康对照。每个参与者都将接受以问卷和DSM-IV结构化临床访谈(SCID)的形式的全面心身评估。参与者的压力水平和日常应激源将使用感知压力量表(PSS)、Trier慢性压力评估问卷(TICS)和每日压力问卷(Alltag sbelastungsfragebogen,ABF)进行评估。实验压力激发将以Trier社会压力测试(TSST)的形式进行。在TSST之前和之后,都将采集血液和唾液样本。血液测试将用于测定葡萄糖、肾上腺素、去甲肾上腺素和ACTH;以及甲基乙二醛和乙二醛及其糖基化终产物,以及总抗氧化能力。此外,唾液测试将被用来测量皮质醇活性。这项研究的一个普遍假设是,反应性代谢物的基础水平与慢性应激指标(如皮质醇、心率和主观测量)呈正相关。此外,假设在急性应激发作后,糖尿病患者亚组的反应性代谢物的动态变化将受到干扰。中心假设是,与没有并发症的患者相比,有并发症的糖尿病患者应激诱导的反应代谢产物的产生和分解之间的失衡将更加突出。据我们了解,该项目是第一个重复测量的三组对照设计,旨在研究慢性应激、急性应激、甲基乙二醛和乙二醛水平(及其变化)与糖尿病并发症的关系。将与SFB 1118“反应性代谢物ALS Ursache糖尿病患者Folgeschäden”(“导致糖尿病并发症的反应性代谢物”)进行密切合作。在更广泛的参考框架下,这项研究将作为可能识别可能从减压治疗中受益的各种应激反应患者群体的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professorin Dr. Beate Wild其他文献

Professorin Dr. Beate Wild的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professorin Dr. Beate Wild', 18)}}的其他基金

Biopsychosocial health care needs and costs of elderly people: a comparison study between Germany and the Netherlands
老年人的生物心理社会保健需求和费用:德国和荷兰的比较研究
  • 批准号:
    321002415
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic Interactions
项目 2:生物标志物分析、非遗传风险因素及其遗传相互作用
  • 批准号:
    10555697
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Prospective Memory in Everyday Life: Lapses and Decline in Relation to Inflammatory and Neurodegenerative Biomarkers in Older Adults
日常生活中的预期记忆:与老年人炎症和神经退行性生物标志物相关的衰退和下降
  • 批准号:
    10644046
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The role of loneliness in cognitive decline and risk for dementia
孤独在认知能力下降和痴呆风险中的作用
  • 批准号:
    10646826
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
  • 批准号:
    10643344
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Preparing for Blood-Based Alzheimer’s Disease Biomarker Testing in Diverse Populations: Development of a Decision-Support Tool for Primary Care
为不同人群进行基于血液的阿尔茨海默病生物标志物测试做好准备:开发初级保健决策支持工具
  • 批准号:
    10722716
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
  • 批准号:
    10726660
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS)
MUSIC 疗法解决镰状细胞病生活质量问题的多部位可行性 (MULTI-MUSIQOLS)
  • 批准号:
    10728452
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Behavioral Interventions for the Treatment of Early Onset Alzheimer's Disease
治疗早发性阿尔茨海默病的行为干预措施
  • 批准号:
    10571346
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The PILI 'Āina Project
PILI äina 项目
  • 批准号:
    10624026
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A neurobiological investigation of cannabis use and misuse in Veterans
退伍军人大麻使用和滥用的神经生物学调查
  • 批准号:
    10588526
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了